ONCOGENEX PHARMACEUTICALS IN's ticker is OGXI and the CUSIP is 68230A106. A total of 55 filers reported holding ONCOGENEX PHARMACEUTICALS IN in Q4 2015. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $4,000 | -33.3% | 5,238 | 0.0% | 0.00% | – |
| Q4 2015 | $6,000 | -50.0% | 5,238 | 0.0% | 0.00% | – |
| Q3 2015 | $12,000 | +33.3% | 5,238 | +33.1% | 0.00% | – |
| Q2 2015 | $9,000 | +28.6% | 3,936 | +17.4% | 0.00% | – |
| Q1 2015 | $7,000 | -12.5% | 3,353 | 0.0% | 0.00% | – |
| Q4 2014 | $8,000 | -11.1% | 3,353 | 0.0% | 0.00% | – |
| Q3 2014 | $9,000 | 0.0% | 3,353 | +32.8% | 0.00% | – |
| Q2 2014 | $9,000 | -98.1% | 2,525 | -93.9% | 0.00% | -100.0% |
| Q1 2014 | $484,000 | +40.3% | 41,196 | -0.5% | 0.00% | 0.0% |
| Q4 2013 | $345,000 | -11.8% | 41,419 | -1.9% | 0.00% | 0.0% |
| Q3 2013 | $391,000 | -0.3% | 42,218 | +5.5% | 0.00% | 0.0% |
| Q2 2013 | $392,000 | – | 40,027 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 1,368,500 | $3,134,000 | 0.61% |
| TANG CAPITAL MANAGEMENT LLC | 365,000 | $836,000 | 0.46% |
| Abingworth LLP | 603,740 | $1,352,000 | 0.38% |
| Cheyne Capital Management (UK) LLP | 150,000 | $338,000 | 0.09% |
| Telemetry Investments, L.L.C. | 50,000 | $114,000 | 0.07% |
| Rotella Capital Management, Inc. | 19,473 | $45,000 | 0.04% |
| SABBY MANAGEMENT, LLC | 461,957 | $1,058,000 | 0.03% |
| Nine Chapters Capital Management LLC | 113,700 | $260,000 | 0.02% |
| STONERIDGE INVESTMENT PARTNERS LLC | 49,471 | $113,000 | 0.02% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 87,388 | $200,000 | 0.01% |